Misonix, Inc. (NASDAQ: MSON) has their efforts focused on designing, developing, and manufacturing one of the broadest ranges of Therapeutic Ultrasonic Medical Devices. The company’s aim is to develop products that will improve patients’ quality of life by incorporating the highest level of quality and innovation into each and every product. Current application of their technology ranges from kidney stone pulverization and the aspiration of brain tumors to the latest technological breakthrough HIFU (High Intensity Focused Ultrasound) for various cancer treatments. For further information, visit the Company’s web site at www.misonix.com.
- 17 years ago
QualityStocks
Misonix, Inc. (NASDAQ: MSON)
Tags Rodman & Renshaw
Related Post
-
Perpetuals.com Ltd. (NASDAQ: PDC) Completes BayesShield(TM) AI Pilot, Reporting 92% Block Rate on Losing Retail Crypto Trades
The BayesShield AI system analyzed a full year of real retail trading data to validate…
-
QualityStocksNewsBreaks – SPACSphere Acquisition Corp. (NASDAQ: SSACU) Closes $172.5 Million Initial Public Offering
SPACSphere Acquisition (NASDAQ: SSACU) announced the closing of its initial public offering of 17,250,000 units…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Featured by RADIO + TELEVISION BUSINESS REPORT for ADIO Engagement Platform and Real-Time Bias Meter
Datavault AI (NASDAQ: DVLT) is highlighted in the Winter 2026 issue (p. 27) of RADIO + TELEVISION BUSINESS REPORT, which examines…